commercializes therapeutics

Related by string. * Commercialize . Commercializes : commercializes innovative therapeutics . commercializes innovative biopharmaceuticals . commercializes differentiated products / THERAPEUTICS . THERAPEUTIC . Therapeutics : small molecule therapeutics . Qualifying Therapeutic Discovery * commercializes therapeutic proteins . commercializes therapeutic products *

Related by context. All words. (Click for frequent words.) 66 infectious diseases autoimmune diseases 65 novel RNAi therapeutics 65 Anticipating Flossie 65 acetonide FA 64 kidney urologic 64 gastro intestinal inflammation 64 commercializes innovative 64 BioMarin develops 63 targeted anticancer biopharmaceuticals 63 genomics proteomics cellular 63 superior ophthalmologic products 63 commercializes biotherapeutics 63 Provectus Pharmaceuticals specializes 63 commercializes innovative biopharmaceuticals 63 commercializing therapeutic 62 NovaBay Aganocide compounds 62 Opterone R 62 CCR9 antagonist 62 acne impetigo 62 commercializing anti infective 62 Friedreich Ataxia FRDA 62 pelvic malignancies 62 technology visit http:/www.genmab.com 61 novel immunotherapies 61 commercialize Aganocides 61 manufactures minimally invasive 61 commercializes oncology 61 recombinant biopharmaceutical 61 diagnostic molecular imaging 61 anti atherothrombotic 61 ALN HTT 61 immunotherapeutic approaches 61 TTR amyloidosis 61 immunological diseases 61 Prodarsan R 61 P#X# antagonist 61 subsidiary Cira Biosciences 61 CYT# potent vascular disrupting 61 candidates Azedra TM 61 ALN PCS 61 Nanobody R 61 Stapled Peptide 61 including eniluracil ADH 61 Addex Pharmaceuticals www.addexpharma.com discoverMunsif Khan spokesman 61 Therapies SRT 61 Genasense evaluating 60 ASONEP TM 60 novel therapeutic antibodies 60 XmAb ® 60 skeletal muscle weakness 60 Liprotamase 60 positioned Aastrom 60 Nasdaq MNKD focused 60 Cobalamin TM mediated 60 DPX Survivac 60 novel antiviral therapeutics 60 investigational monoclonal antibody 60 delay bone metastases 60 TRACON Pharmaceuticals 60 neuro inflammatory disorders 60 Nasdaq LXRX biopharmaceutical 60 acquires researches develops 60 vitreoretinal disorders 60 genetics immunology 60 Amex PTN 60 endocrine diseases 60 Teras vision 60 lead molecular radiotherapeutic 59 posterior uveitis 59 molecular chaperone regulation 59 neovascular diseases 59 delivers fluocinolone acetonide FA 59 Nasdaq IDIX biopharmaceutical 59 oncolytic virus therapies 59 Vitrasert ® 59 commercialize deforolimus 59 macular degeneration diabetic retinopathy 59 Inc. AMEX YMI 59 diseases fat malabsorption 59 antiangiogenesis therapies 59 liposomal ciprofloxacin 59 hematologic disorders 59 visit www.genmab.com 59 Corp. Nasdaq BSTC 59 either acutely decompensated 59 Aganocide ® 59 sodium thiosulfate STS 59 purinergic receptors P#X# 59 humanised monoclonal antibody 59 OTCBB NVLT biopharmaceutical 59 Neoprobe subsidiary Cira 59 immunotherapeutics 59 Aviptadil 59 relapsed leukemia 59 anti infective treatments 59 developing Surfactant Replacement 59 NYSE Amex RNN 59 Ribavirin causes 59 NYSE Amex AEN 59 tropical parasitic 59 Inc. Nasdaq IMGN 59 osteolytic bone disease 59 www.ucb group.com 59 autoimmune inflammatory 59 modified glutathione analog 59 Hepatitis C Virus HCV 59 neuro inflammatory 59 RNAi therapeutic platform 59 blood coagulation disorders 58 Martin Nicklasson CEO 58 signal averaging electrocardiography 58 pharmacological chaperone 58 rusalatide acetate 58 Vitrasert R 58 invasive candidiasis 58 inflammatory autoimmune diseases 58 programs visit http:/www.bionovo.com 58 systemic RNAi 58 theranostic 58 Combivir Kivexa 58 plasmid DNA pDNA 58 Selzentry Celsentri 58 constipation OIC 58 fusion enhancers 58 hectare Carscallen Property 58 FOLOTYN ® 58 oropharyngeal candidiasis OPC 58 liver cancers hypercholesterolemia 58 molecular imaging radiopharmaceuticals 58 Announces Poster Presentations 58 oral ghrelin agonist 58 therapeutic monoclonal antibodies 58 including acne photodamage 58 Therapeutic Competitors Companies 58 ophthalmic therapeutics 58 anticancer therapeutics 58 monoclonal antibody therapeutics 58 Inc. NASDAQ IDMI 58 antibody MAb 58 Nasdaq ALNY 58 inherited metabolic disorders 58 rxRNA 58 commercializing novel biotherapeutics 58 cystic fibrosis chronic pancreatitis 58 dermatology therapies 58 Nasdaq OSIP 58 Spectrum Pharmaceuticals acquires 58 biologic therapeutics 58 asthma COPD Chronic 58 LHRH antagonists 58 aerosolized AAT 58 Cancidas 58 Surfactant Replacement Therapies SRT 58 antiplatelet medications 58 menopause contraception 58 cosmetic cosmeceutical products 58 preclinical compounds 58 Viprovex TM 58 topical anti infective 58 candidates Azedra 58 Atrigel 58 commercialize XP# 58 TransVax ™ 58 novel emulsion formulation 58 Lighted arrow boards 58 brand ciclesonide HFA 58 Hana Biosciences NASDAQ HNAB 58 vascular occlusive diseases 58 proliferative diseases 58 oral PTH 58 Predictive medicine 58 immunology oncology 58 NASDAQ SNTA biopharmaceutical 58 gastrointestinal mucositis 58 interferon alpha IFN 58 Nasdaq IMGN 58 antibody fragment therapeutics 58 include ClindaReach TM 57 please visit www.eisai.com 57 gastroenterology neurology 57 immuno inflammatory diseases 57 Rhucin ® recombinant 57 ocular infections 57 Glencore Vena 57 commercialize SGN 57 Exelixis compounds 57 hepatitis C lupus 57 R Saizen R 57 LymphoStat B TM 57 visit www.targanta.com 57 Fibrin MB 57 induced mucositis 57 including thyroiditis RA 57 HuMax TAC 57 diabetic gastroparesis 57 immunologic diseases 57 BioSilicon TM 57 siRNA therapeutics 57 Cytogen marketed 57 diagnosing infectious diseases 57 non alcoholic steatohepatitis 57 molecular imaging pharmaceuticals 57 CINTREDEKIN BESUDOTOX 57 Morria Biopharmaceuticals Plc 57 XmAb ™ 57 Severe VOD 57 Mycograb 57 Warner Chilcott Actonel 57 pralatrexate injection folate analogue 57 MediGene focuses 57 Inc. NASDAQ AEZS 57 IMiDs 57 systemic lupus erythematosus psoriasis 57 psoriasis rheumatoid arthritis 57 ophthalmic diseases 57 Artillery barrages preceded 57 gastrointestinal GI motility disorders 57 xMAP Technology 57 oral prodrug 57 myocardial infarction ventricular fibrillation 57 RNAi therapeutic targeting 57 personalized cellular immunotherapy 57 diarrhea predominant irritable 57 Generx TM 57 MyVax R 57 Brussels THR 57 anticancer therapy 57 Amgen discovers develops 57 nephropathic cystinosis cystinosis 57 SMARTICLES ® 57 vitro diagnostic tests 57 mGluR4 activation 57 targeted immunotherapies 57 HYVISC R 57 Nasdaq ASTM 57 Selective Electrochemical Tumor Ablation 57 vinca alkaloid 57 include VALSTAR TM 57 CellCept mycophenolate mofetil 57 anti infective compounds 57 novel VDA molecule 57 AAG geldanamycin analog 57 Fibromyalgia Syndrome FMS 57 INS# [001] 57 develops allosteric modulators 57 NASDAQ BTRX pharmaceutical 57 erlotinib Tarceva ® 57 hyperphenylalaninemia HPA due 57 inflammatory autoimmune 57 target Galectin receptors 57 immunodeficiency disorders 57 humanized monoclonal antibodies 57 Acute Radiation Syndrome ARS 57 AMEX KAL 57 valacyclovir Valtrex 57 TSX YM AIM 57 progressive metastatic prostate 57 musculoskeletal metabolic 57 5 lipoxygenase inhibitor 57 SNALP 57 oncology infectious diseases 57 Initiates Phase II 57 IMiDs ® compound 57 multi kinase inhibitor 57 Inotek Pharmaceuticals Corporation 57 repopulate neural 57 Levulan ® PDT 57 severe dermatologic toxicities 57 OTCBB INSV 57 fungal infections malaria tuberculosis 57 adrenal steroid hormones 57 leukemia lymphoma multiple myeloma 57 lupus multiple sclerosis 57 DepoCyt 56 Zemiva TM 56 neurology immunology 56 Amgen discovers develops manufactures 56 Cx# [002] 56 included exfoliative dermatitis 56 OLIGON technology 56 renal diseases 56 Ebola virus infection 56 NASDAQ OPXA 56 product platforms AZX# 56 oral JAK#/JAK# inhibitor 56 LentiVector technology 56 endocrinology gastroenterology 56 equine osteoarthritis marketed 56 commercializing proteomics discoveries 56 platform HDL Mimetic 56 Corp. NASDAQ PSDV 56 HepDirect R 56 Personalized Immunotherapy 56 lymphoma myeloma 56 regarding Aethlon Medical 56 Oracea TM 56 PNP inhibitor 56 Nasdaq HALO biopharmaceutical 56 hematological diseases 56 voiding dysfunctions 56 Solazed TM 56 CholeraGarde R Peru 56 GERD migraine headaches 56 cirrhosis liver failure 56 Inc. OTCBB ECTE 56 neuroscience autoimmune 56 treating cancerous tumors 56 muscular dystrophy cystic fibrosis 56 damage cirrhosis liver 56 therapeutic monoclonal antibody 56 Nasdaq DSCI 56 identify protein biomarkers 56 toenail onychomycosis 56 pharma.com 56 topical dermatology 56 Fleximer R 56 KL4 surfactant 56 equine osteoarthritis 56 Hereditary angioedema HAE 56 photodisinfection 56 Tekmira SNALP 56 OTCQB ABPI 56 topically delivered 56 Nanobody ® 56 Inc. ProMetic www.prometic.com 56 Inc. Nasdaq VIAP 56 pharmacogenomic tests 56 vaginal candidiasis 56 Celacade TM 56 autologous cellular therapies 56 Squalamine 56 hepatocellular carcinoma liver 56 trastuzumab Herceptin ® 56 herpetic keratitis 56 NYSE Amex NBY clinical 56 expanded autologous cellular 56 Maven Semantic 56 PORxin TM platforms 56 IMiDs R 56 prostone 56 chemistry microbiology immunology 56 ALN TTR# 56 commercializing oxidized glutathione 56 HQK 56 candidate Zemiva 56 HCV protease inhibitors 56 myelofibrosis polycythemia vera 56 Nasdaq MITI biopharmaceutical 56 sapropterin dihydrochloride Tablets 56 recurrent glioblastoma multiforme 56 hypertension osteoarthritis 56 MAXY VII 56 Dyax phage display 56 thetreatment 56 AKIP ™ 56 commercial bioproduction 56 peptide peptide mimetic 56 collagen vascular 56 cellular immunotherapy 56 lupus hepatitis C 56 transthyretin TTR mediated amyloidosis 56 biased ligand 56 leading lipid nanoparticle 56 acting fibrinolytic 56 OTCBB PYTO 56 developing Surfactant Therapies 56 Onalta 56 Nasdaq PARD 56 molecular imaging radiopharmaceutical 56 Nasdaq MSON designs 56 intranasal delivery 56 isoform selective 56 Tumour Vascular Disrupting Agent 56 ELADUR ™ 56 catalytic antioxidant compounds 56 Locked Nucleic Acid 56 include Healive TM 56 NASDAQ ACHN 56 Allos retains exclusive 56 pharmacogenomic translational research 56 Bronson Slope Project 56 Tibotec Therapeutics division 56 infectious diseases autoimmune 56 Trafigura Vena 56 novel antibody therapeutics 56 ddRNAi 56 www.syntapharma.com 56 introduced NEUGENE 56 treat male hypogonadism 56 dermatological diseases 56 candidate TNFerade biologic 56 Nasdaq CNCT specialty 56 Pruvel TM 56 OTCBB HXBM developer 56 transthyretin mediated amyloidosis ATTR 56 ophthalmology dermatology 56 hematological disorders 56 Retisert ® 56 CD# CEA 56 selectively inhibit replication 56 sirtuin inhibitor program 56 OTCBB PWRM.OB 56 Immunotherapeutic 56 dermaceuticals 56 Nasdaq VRTX 56 Celator 56 HYVISC ® treatment 56 superficial basal cell carcinoma 56 dasatinib Sprycel 56 Adnectin 56 proprietary biomaterials 56 molecular biomarkers 56 NuMimetic TM 56 OTCBB QTXB 56 www.pranabio.com 56 cognitive impairment associated 55 endocrine therapies 55 therapeutic biomaterials 55 inflammation autoimmune diseases 55 anti secretory 55 Homspera TM 55 autoimmune cardiovascular 55 KETEK 55 StromaCel Inc. 55 vaccines oncolytic virus 55 About MIGENIX MIGENIX 55 NASDAQ OPTR 55 Nursing NCSBN composed 55 Familial Adenomatous Polyposis FAP 55 OTCBB URGP specialty 55 oncolytic viruses 55 iSONEP TM 55 novel peptide therapeutics 55 IAP inhibitor 55 Nasdaq DVAX 55 recurrent metastatic ovarian cancer 55 leukemia APL 55 deCODE ProstateCancer TM 55 antiviral therapeutics 55 Amex KAL 55 markets biosurgical 55 OnDose TM 55 metaglidasen 55 DURECT proprietary 55 estrogen receptor beta agonist 55 cardiovascular metabolic 55 Pazopanib 55 mda 7 55 ATTR CM 55 Ozurdex 55 AKT inhibitor 55 polyneuropathy HIV DSP 55 IAP inhibitors 55 Sebivo 55 PRNewswire Sinovac Biotech 55 website www.novavax.com 55 MEDA AB publ 55 microtubule inhibitor 55 rheumatoid arthritis Crohn disease 55 CYT# novel 55 NYSE Amex YMI 55 sickle cell cystic fibrosis 55 Oncaspar 55 therapeutic anticancer 55 hyperplasia BPH 55 http:/www.anadyspharma.com 55 targets TRPM8 55 Nasdaq SLXP 55 Revimmune TM 55 hereditary retinal 55 RECOTHROM ® 55 novel anti infective 55 superior bioprocessing 55 PDE# inhibitors 55 therapeutic peptide 55 lcati@equityny.com 55 human antibody therapeutics 55 arthritis cardiovascular disease 55 passive immunotherapy products 55 Hsp# inhibition 55 Anthracycline 55 NTDDS 55 Inc. NASDAQ BPAX 55 dermatological disorders 55 TNF alpha antagonist 55 therapeutics diagnostics 55 http:/www.appliedbiosystems.com/ 55 syndrome overactive bladder 55 NASH Huntington 55 p# inhibitor 55 EHT AGN 55 romazarit 55 RNA antagonists 55 commercialize becocalcidiol patented 55 Hereditary angioedema 55 allogeneic HSCT 55 phenylketonuria PKU developed 55 urologic disease 55 visit http:/www.neogenomics.org 55 Inc. OTCBB OXIS 55 NASDAQ INGN 55 NASDAQ MSON developer 55 secretory diarrhea 55 product AMD# 55 virology therapeutics 55 diabetic retinopathy DR 55 YM AIM YMBA 55 CINtec R 55 AN# novel 55 ICx develops 55 Aeolus Pharmaceuticals Announces 55 lymphoma leukemia 55 Nasdaq CRXL 55 NASDAQ DCTH 55 visit www.virtualscopics.com 55 novel peptide 55 Ceragenin ™ 55 oncology urology 55 selective angiogenic kinase inhibitor 55 Alternext ALEHT 55 hereditary emphysema 55 please visit http:/www.sunesis.com 55 CDP# 55 Luveris R Ovidrel R 55 trademarks Vitrasert R 55 immunoregulation 55 TSX PMD 55 Alessandro Riva 55 autoimmune uveitis 55 Inc. NASDAQ AGIX 55 cancer inflammation autoimmune 55 gastrointestinal stromal tumors GIST 55 antimitotic 55 alpha interferons 55 ATTR PN 55 oncolytic 55 EECP ® therapy 55 ophthalmology oncology 55 Prodarsan ® 55 ophthalmology dermatology cardiovascular disease 55 Soliris eculizumab 55 OTCBB OHRP 55 Temodar ® 55 receiving opioid analgesics 55 patient derived xenografts 55 Company Nasdaq RGDX 54 cystic fibrosis inflammation autoimmune 54 metastatic renal 54 Huntingtons disease 54 Æterna Zentaris Inc. 54 Kit CD# positive 54 Myelodysplastic syndromes MDS 54 NYSE Amex PBTH 54 epilepsy Parkinson disease 54 www.keithley.com events semconfs 54 Prochymal TM 54 Sandy Gerety c o 54 Zalypsis 54 pharmacogenetic test 54 PAION AG ISIN 54 nephrology oncology 54 combining voreloxin 54 DiLA2 54 investigational compounds 54 XSSE OXGN 54 rheumatoid arthritis inflammatory bowel 54 commercializes medicines 54 Nasdaq CLDX 54 Foradil Aerolizer 54 PDE4 inhibitor 54 Darapladib 54 engineered proteases 54 hemorrhagic fever viruses 54 AVI BioPharma develops 54 proprietary PEGylation 54 unadjusted insured 54 HTS assay 54 Cellgate Inc. 54 gynecologic procedures 54 Interventional radiology 54 Tß4 54 Gord Froehlich President 54 NASDAQ AVNR 54 immune globulins 54 dermatologic disorders 54 multiple sclerosis rheumatoid arthritis 54 opioid tolerant adult 54 Nasdaq IDRA 54 ocular inflammatory 54 small molecule tyrosine 54 transdermal gel 54 INSPIRE Trial Phase III 54 factor TNF receptor 54 ZFP Therapeutic 54 overactive bladder syndrome 54 treat gastrointestinal disorders 54 vitamins minerals herbal 54 OHR/AVR# 54 Crop BioScience 54 fibrotic disorders 54 developing chemokine 54 Factor VIIa 54 diagnosing preventing 54 Garo H. 54 GI motility disorders 54 high noon.com 54 antimetabolite 54 ocular diseases 54 PRIME NEWSWIRE Hana Biosciences 54 investigational therapies 54 www.sorin.com 54 anti aging glycopeptides 54 Azmacort R 54 IV Busulfex 54 systemic RNA interference 54 adrenergic regulation 54 induce remission 54 OTCBB NRGX 54 www.uluruinc.com 54 resorbable biomaterials 54 Hepatocellular Carcinoma HCC 54 Inc. OTCBB ALRX 54 test visit www.radient 54 Preclinical studies suggest 54 NASDAQ PPHM clinical 54 Nanobody 54 Millenia Hope develops 54 dopaminergic therapy 54 lichen planus 54 angiogenesis inhibit 54 Crucell genetically engineered 54 TSX BSY 54 blood serum biomarkers 54 ALN TTR 54 KL4 Surfactant 54 Hepatitis C Viral 54 Intravenous immunoglobulin 54 Alfacell Corporation 54 regenerative stem cell 54 immuno inflammatory 54 Peyronie disease Frozen Shoulder 54 Bilive TM combined 54 targeted radiotherapeutics 54 AA Amyloidosis 54 humanized monoclonal 54 Nasdaq DYAX 54 ChimeriVax JE 54 targeted radiotherapeutic 54 PLK1 SNALP 54 autologous cell 54 acne rosacea 54 Kosan dependence 54 small molecule PEGylation 54 treat menorrhagia 54 Deferiprone 54 docetaxel Taxotere ® 54 esophageal candidiasis 54 taxane chemotherapy 54 RNA antagonist 54 taste modulators 54 SIX RO ROG 54 neovascular wet age 54 derivatives Radilex TM 54 commercialize microRNA therapeutics 54 quinine sulfate 54 commercialize Dimebon 54 subsidiary AION Diagnostics 54 anti angiogenic agents 54 orthobiologic 54 Ception Therapeutics 54 regenerating bone 54 inhalation anthrax cutaneous anthrax 54 RNAi therapeutic targeting PCSK9 54 Nasdaq IDIX 54 AMEX RNN 54 Enbrel rheumatoid arthritis 54 OTCBB TDLP 54 hypoxia activated prodrug 54 treat enlarged prostate 54 Nasdaq IMGN biotechnology 54 neuropathic pain metabolic diseases 54 CRMD pharmaceutical 54 BHT DNA 54 efficacious treatments 54 commercializes minimally invasive 54 gastrointestinal disorders characterized 54 BIOGUARD TM 54 GRNOPC1 contains 54 Inc. Nasdaq DSCO 54 www.cmdiagnostics.com 54 Frozen Shoulder Syndrome 54 unresectable recurrent 54 metastatic kidney 54 OTCBB DORB 54 immunoassay kits 54 Ibis T# TM 54 Nasdaq HALO 54 Nasdaq PPHM clinical 54 Gemzar gemcitabine 54 Iluvien TM 54 encapsulates siRNAs 54 fluoroquinolone class 54 proprietary Biochronomer 54 recurrent genital herpes 54 Kuvan sapropterin dihydrochloride 54 MyVax ® 54 recombinant polyclonal antibodies 54 incorporate CXA 54 neurology autoimmune diseases 54 Inc. Nasdaq NGEN 54 discovery anddevelopment 54 platforms GVAX 54 THR beta agonist 54 leaving Doran squinting 54 monocytogenes Listeria vaccines 54 PRNewswire FirstCall YM BioSciences 54 NEBIDO VANTAS SUPPRELIN LA 54 neurology infectious 54 TSX LOR Lorus biopharmaceutical 54 Nasdaq NPSP 54 immuno therapeutic 54 PRNewswire FirstCall Derma Sciences 54 PI3K/Akt pathway inhibitor 54 % uracil topical 54 Dementia Related Psychosis 54 Navelbine R 54 cardiovascular disease autoimmune disorders 54 Pancreas Cancer Vaccine 54 please visit www.metabolon.com 54 phase IIb study 54 neuroinflammatory diseases 54 Myolimus 54 nephrology oncology supportive 54 commercializing interventional 54 NASDAQ BMRN 54 Nasdaq RXII 54 include Altastaph TM 54 Through Glycoscience R 54 myeloproliferative disorders 54 Cerashield ™ 54 LungAlert TM 54 HydroFix TM 54 Resurgex Plus R 54 Inc. NASDAQ CRIS 54 recurrent bladder 53 VANTAS ® 53 thymic carcinoma 53 treat musculoskeletal metabolic 53 prescription dermatological 53 leukotriene pathway 53 cosmeceutical wound 53 bloodroot shark cartilage 53 novel peptides 53 NASDAQ AVEO biopharmaceutical 53 topically applied SEPA 53 brain penetrant 53 OTCBB AEMD pioneer 53 Viagra Soft Cialis Soft 53 ostarine 53 AMEVIVE 53 visit http:/www.amgen.com 53 autoimmune disorders asthma 53 secondary amenorrhea 53 POSIDUR TM ELADUR TM 53 small molecule agonists 53 immuno modulatory 53 biliary tract cancer 53 rheumatoid arthritis thrombocytopenia 53 Nasdaq RGDX 53 Pelvic inflammatory 53 HIV integrase inhibitors 53 stable nucleic acid 53 JAK2 inhibitor 53 subsidiaries InnerCool Therapies 53 Helix BioMedix Inc. 53 Sutent sunitinib 53 DRUG ADMINISTRATION 53 polyomavirus nephropathy 53 OTCBB IMNR 53 A1PI 53 novel immunomodulatory 53 CytoCore develops cost 53 small molecule therapeutics 53 NovaDel oral spray 53 LSUHSC faculty 53 inhaled bronchodilators 53 neuro stimulation 53 lucinactant 53 EPIX Pharmaceuticals Inc. 53 OTC BB PVCT 53 4SC AG ISIN DE# 53 histone deacetylase inhibitor 53 Cephalon GlaxoSmithKline 53 anidulafungin 53 Novelos Therapeutics Inc. 53 signal transduction inhibitors 53 neuroprotective properties 53 rxRNA ™ compounds 53 renin inhibition promising 53 Panzem R 53 Company NASDAQ MDCO 53 colorectal lung 53 coronary stent merged 53 Supernus Pharmaceuticals 53 Troxatyl 53 Nanobodies 53 enhanced skin permeation 53 Campath alemtuzumab 53 eTag assays 53 commercialize Aganocide compounds 53 Actimmune ® 53 biomarkers predictive 53 microbiological sciences 53 palliative radiotherapy 53 polyclonal antibodies 53 GI GVHD common 53 IGIV therapy 53 NASDAQ CYTR biopharmaceutical 53 erlotinib Tarceva 53 NYSE Amex JAV 53 prostate cancer benign prostatic 53 RNAi therapeutic 53 LNP formulations 53 Nasdaq ENMD 53 SNALP technology 53 monoclonal antibody therapies 53 NASDAQ VRTX 53 TSX CTI 53 bio therapeutics 53 BIOGUARD ® 53 Nasdaq XTLB 53 Lixivaptan 53 diagnostic prognostic 53 proliferative disorders 53 treatmentof 53 Barrier Therapeutics Inc. 53 Nasdaq AVNR 53 herpes simplex viruses 53 cytomegalovirus immune globulin 53 cardiotoxic 53 retinal transplantation 53 Tutoplast Process R 53 adipose stem 53 Nasdaq SPPI 53 OvaRex R 53 nitric oxide donating 53 ALN RSV program 53 HIV AIDS neuropathic pain 53 excessive menstrual bleeding 53 commercializes therapeutic products 53 NASDAQ SNTA 53 AMEX REX 53 drug metabolism bioavailability 53 HSP# inhibitors 53 PDE4 modulators 53 targeting CD# 53 Kepivance 53 AMEX RGN 53 commercialize MDV# 53 immunotherapeutic vaccine 53 Roche Herceptin 53 neuroendocrine cancers 53 degenerative disorders 53 nasal peptide 53 ZFN TM 53 Vitamin D analogue 53 NexACT 53 sodium stibogluconate 53 Cobalamin TM 53 PRNewswire FirstCall Aeterna Zentaris 53 genitourinary tract 53 Cethrin R 53 include Healive 53 recurrent herpes labialis 53 erythema nodosum 53 OTCBB PVCT 53 topical formulations 53 VersaFilm 53 NEUGENE R 53 therapeutics 53 Shark cartilage 53 opioid analgesia 53 Alvine Pharmaceuticals 53 AMEX INO 53 oral dihydropyrimidine dehydrogenase DPD 53 candidate epratuzumab 53 candidate Zenvia 53 accessories autologous 53 relapsed ALL 53 Nanobodies ® 53 Stargardt Macular Dystrophy SMD 53 ImmuneRegen BioSciences Inc. 53 rheumatoid arthritis osteoarthritis ankylosing 53 Chronic illnesses 53 antiinfective products 53 ribonucleotide reductase clinically validated 53 C1 esterase inhibitor 53 prophylactic vaccines 53 methylation markers 53 Gleevec imatinib mesylate 53 Eg5 kinesin spindle 53 InfaCare Pharmaceutical Corporation 53 Viprovex R 53 chronic rheumatic 53 pituitary disorders 53 Amgen Neulasta ® 53 KIACTA ™ 53 Nasdaq CYTR biopharmaceutical 53 Oncology Primary Care 53 intranasal insulin product 53 Nasdaq OPTR 53 drug conjugates ADCs 53 Epeius Biotechnologies Corporation 53 Surfaxin LS 53 Nasdaq IMMU biopharmaceutical 53 Archexin 53 exocrine pancreatic insufficiency EPI 53 NASDAQ MGRM 53 Hepatitis B Hepatitis C 53 ocular disorders 53 immunotherapy treatments 53 therapeutic modalities 53 Inc. Nasdaq ONTY 53 cyclophilin inhibitors 53 barrier gauze dressings 53 inherited retinal degeneration 53 ECD Ovonics proprietary 53 multiple sclerosis amyotrophic lateral 53 Ampakine compounds 53 Azedra 53 Inc. Nasdaq FVRL 53 PROfusion 53 antisense drugs 53 SARMs 53 psoriasis psoriatic arthritis 53 OTCBB CHKT biotechnology 53 tools fragrances skincare 53 subcutaneous immunoglobulin 53 HuLuc# 53 HSP# inhibitor 53 Unit Dose Budesonide 53 systemic scleroderma 53 Ostabolin C TM 53 Dual Opioid 53 Inc CRIS 53 Nasdaq IVGN 53 NASDAQ EPIX 53 candidate custirsen 53 muco adhesive technology 53 oral PTH technology 53 retinal disorders 53 Neovasc Reducer TM 53 corticosteroid therapy 53 ARRY # 53 oncology neurology 53 Nasdaq PDGI 53 anti thrombotics 53 ELACYT 53 atrial fibrillation budiodarone ATI 53 polymer conjugate technology 53 protein misfolding diseases 53 Balloon sinuplasty 53 transplantation biology 53 Alseres Cethrin 53 psoriasis vulgaris 53 Kamada AAT 53 Frozen Shoulder syndrome Adhesive 53 lives manufactures RISPERDAL 53 Gastro intestinal 53 refractory angina 53 Biomoda www.biomoda.com 53 OTCBB NRGX biotechnology 53 OTCBB FCSC 53 chemical peels microdermabrasion 53 peripheral arterial occlusive disease 53 HuCAL PLATINUM ® CysDisplay 53 calcitonin manufacturing 53 Staphylococcus aureus Immune Globulin 53 Altera Nebulizer System 53 OxBC 53 Parkinson disease Alzheimer disease 53 Listeria vaccine 53 Atripla combines 53 Tectin TM 53 TSX TKM 53 Roche SWX ROG 53 nephropathy kidney 53 NASDAQ LGND 53 proprietary chemically modified 53 Chrysalin 53 Eurand NV NASDAQ EURX 53 gastroenterology obstetrics gynecology 53 Myocet 53 Adenosine Therapeutics 52 PROGENSA R 52 oncology virology 52 multiple sclerosis inflammatory bowel 52 Unigene nasal calcitonin 52 NASDAQ IMCL

Back to home page